Disposition kinetics and urinary excretion of ciprofloxacin in goats following single intravenous administration

Journal of Veterinary Science

Volumn 9, Issue 3, 2008, Pages 241-245

  Raina, R ^a   Prawez, S ^a   Dimitrova, D J ^b   Pankaj, N K ^a   Verma, P K ^a  

^a SHER E KASHMIR UNIVERSITY OF AGRICULTURAL SCIENCES AND TECHNOLOGY OF JAMMU   (India)

^b TRAKIA UNIVERSITY   (Bulgaria)

Author keywords

Ciprofloxacin; Disposition kinetics; Goat; Urinary excretion

Indexed keywords

BACTERIA (MICROORGANISMS); CAPRA HIRCUS; NEGIBACTERIA;

EID: 50849136821     PISSN: 1229845X     EISSN: None     Source Type: Journal    
DOI: 10.4142/jvs.2008.9.3.241     Document Type: Article

References (40)

1. Abadía AR, Aramayona JJ, Muñoz MJ, Pla Delfina JM, Saez MP, Bregante MA. Disposition of ciprofloxacin following intravenous administration in dogs. J Vet Pharmacol Ther 1994, 17, 384-388.
2. Albarellos GA, Kreil VE, Landoni MF. Pharmacokinetics of ciprofloxacin after single intravenous and repeat oral administration to cats. J Vet Pharmacol Ther 2004, 27, 155-162.
3. Baggot JD. Principles of Drug Distribution in Domestic Animals: The Basis of Veterinary Clinical Pharmacology. pp. 144-189, Saunders, Philadelphia, 1977.
4. Barriere SL, Kaatz GW, Schaberg DR, Fekety R. Altered pharmacokinetic disposition of ciprofloxacin and vancomycin after single and multiple doses in rabbits. Antimicrob Agents Chemother 1987, 31, 1075-1078.
5. Bennett JV, Brodie JL, Benner EJ, Kirby WM. Simplified, accurate method for antibiotic assay of clinical Specimens. Appl Microbiol 1966, 14, 170-177.
6. Campoli-Richards DM, Monk JP, Price A, Benfield P, Todd PA, Ward A. Ciprofloxacin: A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 1988, 35, 373-447.
7. Craig WA. Pharmacokinetic/Pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 1998, 26, 1-10.
8. Dowling PM, Wilson RC, Tyler JW, Duran SH. Pharmacokinetics of ciprofloxacin in ponies. J Vet Pharmacol Ther 1995, 18, 7-12.
9. El-Seidi IA. Effect of pregnancy and lactation on pharmacokinetic properties of ciprofloxacin in rabbits. Wiener Tierarztliche Monatsschrift 2000, 87, 147-152.
10. Fang BH, Feng QH, Chen ZL, Wang ZQ. Bioavailability and Pharmacokinetics of ciprofloxacin in pigs. Chinese J Vet Sc 1999, 19, 588-590.
11. Gibaldi M, Perrier D. Pharmacokinetics. 2nd ed. pp. 1-494, Dekker, New York, 1982.
12. Hackbarth CJ, Chamers HF, Stella F, Shibl AM, Sande MA. Ciprofloxacin in experimental Pseudomonas aeruginosa meningitis in rabbits. J Antimicrob Chemother 1986, 18 (Suppl D), 65-69.
13. Heinzel G, Woloszczak R, Thomann P. Topfit Version 2.0: Pharmacokinetic and Pharmacodynamic Data Analysis System for PC. Gustav Fischer Verlag GmbH, Jena, 1993.
14. Höffken G, Lode H, Prinzing C, Borner K, Koeppe P. Pharmacokinetics of ciprofloxacin after oral and parenteral administration. Antimicrob Agents Chemother 1985, 27, 375-379.
15. Jayakumar K, Honnegowda, Narayana K. Pharmacokinetics of ciprofloxacin in lactating cows. Indian Vet J 2000, 77, 765-767.
16. Joos B, Ledergerber B, Flepp M, Bettex JD, Lthy R, Siegenthaler W. Comparison of high-pressure liquid chromatography and bioassay for determination of ciprofloxacin in serum and urine. Antimicrob Agents Chemother 1985, 27, 353-356.
17. Kumar R, Kumar V, Verma SP, Uppal RP. Pharmacokinetics of ciprofloxacin in cow calves. Indian J Anim Sci 1997, 67, 505-506.
18. Kunin CM. Clinical pharmacology of the new penicillins. 1. The importance of serum protein binding in determining antimicrobial activity and concentration in serum. Clin Pharmacol Ther 1966, 7, 166-179.
19. Lees P, Shojaee Aliabadi F. Rational dosing of antimicrobial drugs: animals versus humans. Int J Antimicrob Agents 2002, 19, 269-284.
20. Leysen DC, Haemers A, Pattyn SR. Mycobacteria and the new quinolones. Antimicrob Agents Chemother 1989, 33, 1-5.
21. Lode H, Borner K, Koeppe P. Pharmacodynamics of fluoroquinolones. Clin Infect Dis 1998, 27, 33-39.
22. Munoz MJ, Llovería P, Santos MP, Abadía AR, Aramayona JJ, Bregante MA. Pharmacokinetics of ciprofloxacin in sheep after single intravenous or intramuscular administration. Vet Q 1996, 18, 45-48.
23. Neer TM. Clinical pharmacologic features of fluoroquinolone antimicrobial drugs. J Am Vet Med Assoc 1988, 193, 577-580.
24. Neu HC. Ciprofloxacin: a major advance in quinolone chemotherapy. Am J Med 1987, 82 (Suppl 4A), 1.
25. Nouws JFM, Mevius DJ, Vree TB, Baars AM, Laurensen J. Pharmacokinetics, renal clearance and metabolism of ciprofloxacin following intravenous and oral administration to calves and pigs. Vet Q 1988, 10, 156-163.
26. Park SC. Pharmacokinetics of ciprofloxacin after intravenous and intramuscular administration in healthy horses. Indian Vet J 2002, 79, 904-908.
27. Prescott JF, Yielding KM. In vitro susceptibility of selected veterinary bacterial pathogens to ciprofloxacin, enrofloxacin and norfloxacin. Can J Vet Res 1990, 54, 195-197.
28. Pu SJ, Feng QH. Pharmacokinetics of ciprofloxacin and its concentrations in milk and udder tissues in goats with endotoxin induced mastitis. Chin J Vet Sci 2000, 20, 271-274.
29. Raina R, Garg BD, Uppal RP, Jain SK, Rana RD. Pharmacokinetics and urinary excretion of ciprofloxacin in goats. Indian J Pharmacol 1994, 26, 83-87.
30. Raina R, Uppal RP, Kumar V, Garg BD. Pharmacokinetics and dosage of ciprofloxacin in buffalo calves. Indian J Anim Sci 2000, 70, 475-477.
31. Schwarz G. Estimating the dimension of a model. Ann Stat 1978, 6, 461-464.
32. Shojaee AliAbadi F, Lees P. Antibiotic treatment for animals: effect on bacterial population and dosage regimen optimisation. Int J Antimicrob Agents 2000, 14, 307-313.
33. Siefert HM, Maruhn D, Maul W, Förster D, Ritter W. Absorption, concentrations in plasma, metabolism and excretion after a single administration of [14C] ciprofloxacin in albino rats and rhesus monkeys. Drug Res 1986, 36, 1496-1502.
34. Singh K, Srivastava AK. Pharmacokinetics and urinary excretion of ciprofloxacin in crossbred cow calves. Indian J Anim Sci 2000, 70, 1021-1024.
35. Toutain PL, Lees P. Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine. J Vet Pharmacol Ther 2004, 27, 467-477.
36. Turnidge J. Pharmacokinetics and Pharmacodynamics of fluoroquinolones. Drugs 1999, 58 (Suppl 2), 29-36.
37. Walker RD, Stein GE, Hauptman JG, MacDonald KH, Budsberg SC, Rosser EJ Jr. Serum and tissue cage fluid concentrations of ciprofloxacin after oral administration of the drug to healthy dogs. Am J Vet Res 1990, 51, 896-900.
38. Walker RD. The use of fluoroquinolones for companion animal antimicrobial therapy. Aust Vet J 2000, 78, 84-90.
39. Watts JL, Salmon SA, Sanchez MS, Yancey RJ Jr. In vitro activity of premafloxacin, a new extended-spectrum fluoroquinolone, against pathogens of veterinary importance. Antimicrob Agents Chemother 1997, 41, 1190-1192.
40. Yamaoka K, Nakagawa T, Uno T. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm 1978, 6, 165-175.